BizJournals -- A budding crop of Central Ohio biotech firms likely will welcome changes starting this month in the federal approval process for low-risk medical devices. The U.S. Food and Drug Administration this year released a 25-point plan to be implemented over the course of 2011 to simplify and make more consistent the review of applications for new devices.
